Peripheral blood CD4(+) cell ATP activity measurement to predict HCC recurrence post‐DCD liver transplant

BACKGROUND AND AIM: Hepatocellular carcinoma (HCC) recurrence after orthotopic liver transplantation (OLT) continues to confound transplant surgeons and physicians. There are no effective methods to predict the patients at risk for recurrence so far although many studies have sought meaningful bioma...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, W., Zhong, H., Zhuang, L., Yu, J., Xu, X., Wang, W., Zhang, M., Zhou, L., Zheng, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Clinical Practice of Organ Transplantation in China. Guest editor: Prof. Shu‐sen Zheng. Publication of this supplement was supported by Novartis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347958/
https://www.ncbi.nlm.nih.gov/pubmed/27197999
http://dx.doi.org/10.1111/ijcp.12811

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347958/
https://www.ncbi.nlm.nih.gov/pubmed/27197999
http://dx.doi.org/10.1111/ijcp.12811

Ejemplares similares